Daiwa Securities Group
TBIO

Daiwa Securities Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Daiwa Securities Group’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-140
Closed -$4K – 1361
2021
Q2 		$4K Hold
140
– – ﹤0.01% 1101
2021
Q1 		$2K Hold
140
– – ﹤0.01% 1174
2020
Q4 		$3K Sell
140
-203
-59% -$3.63K ﹤0.01% 1104
2020
Q3 		$5K Buy
343
+56
+20% +$863 ﹤0.01% 1099
2020
Q2 		$3K Hold
287
– – ﹤0.01% 1152
2020
Q1 		$3K Hold
287
– – ﹤0.01% 1151
2019
Q4 		$2K Hold
287
– – ﹤0.01% 1179
2019
Q3 		$3K Hold
287
– – ﹤0.01% 1114
2019
Q2 		$4K Hold
287
– – ﹤0.01% 1123
2019
Q1 		$3K Sell
287
-363
-56% -$2.78K ﹤0.01% 1119
2018
Q4 		$5K Buy
+650
New +$4.76K ﹤0.01% 1066

Daiwa Securities Group's TBIO Position: Q3 2021 in Review

Daiwa Securities Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 140 shares — an estimated $4K sold.

Daiwa Securities Group first reported a position in TBIO in Q4 2018 and held it in 11 quarters. The position peaked at $5K in Q3 2020. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Daiwa Securities Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 140 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $4K.
  • Daiwa Securities Group first reported a position in Translate Bio, Inc. Common Stock in Q4 2018 and held it in 11 quarters.
  • Daiwa Securities Group's Translate Bio, Inc. Common Stock position peaked at $5K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.